$425.76
0.20%
Nasdaq, Sep 25, 04:06 pm EDT. Closed.
ISIN
US8716071076
Symbol
SNPS

Synopsys Target price 2026 - Analyst rating & recommendation

Synopsys Classifications & Recommendation

Buy
81%
Hold
16%
Sell
3%

Synopsys Price Target

Target Price $571.20
Price $425.76
Potential 34.16%
Number of Estimates 28
28 Analysts have issued a price target Synopsys 2027 . The average Synopsys target price is $571.20. This is 34.16% higher than the current stock price. The highest price target is $664.65 56.11% , the lowest is $418.92 1.61% .
A rating was issued by 32 analysts: 26 Analysts recommend Synopsys to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Synopsys stock has an average upside potential 2027 of 34.16% . Most analysts recommend the Synopsys stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Oct '25 Oct '26
Estimates
Revenue Billion $ 2.25 2.61
37.83% 15.71%
EBITDA Margin 12.30% 47.18%
36.10% 283.57%
Net Margin 19.90% 30.90%
70.78% 55.28%

29 Analysts have issued a sales forecast Synopsys 2026 . The average Synopsys sales estimate is

$9.9b
unlock
. This is
5.30% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$10.3b 8.93%
unlock
, the lowest is
$9.5b 0.90%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $7.1b 15.12%
2026
$9.9b 40.57%
unlock
2027
$11.0b 10.99%
unlock
2028
$12.3b 11.55%
unlock
2029
$13.2b 7.37%
unlock
2030
$14.5b 10.17%
unlock
2031
$16.0b 10.22%
unlock
2032
$17.7b 10.26%
unlock
2033
$19.3b 9.58%
unlock

22 Analysts have issued an Synopsys EBITDA forecast 2026. The average Synopsys EBITDA estimate is

$4.4b
unlock
. This is
164.04% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.0b 203.84%
unlock
, the lowest is
$3.9b 135.99%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $1.1b 22.31%
2026
$4.4b 296.04%
unlock
2027
$5.0b 14.23%
unlock
2028
$4.8b 4.01%
unlock
2029
$4.8b 1.14%
unlock
2030
$5.3b 11.95%
unlock
2031
$5.9b 10.99%
unlock
2032
$6.5b 10.61%
unlock
2033
$7.2b 9.98%
unlock

EBITDA Margin

2025 15.70% 32.52%
2026
44.23% 181.73%
unlock
2027
45.52% 2.92%
unlock
2028
39.17% 13.95%
unlock
2029
36.06% 7.94%
unlock
2030
36.65% 1.64%
unlock
2031
36.90% 0.68%
unlock
2032
37.02% 0.33%
unlock
2033
37.15% 0.35%
unlock

30 Synopsys Analysts have issued a net profit forecast 2026. The average Synopsys net profit estimate is

$2.9b
unlock
. This is
171.25% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$3.1b 183.69%
unlock
, the lowest is
$2.7b 151.00%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $1.3b 41.14%
2026
$2.9b 119.20%
unlock
2027
$3.4b 17.56%
unlock
2028
$4.1b 18.39%
unlock
2029
$4.4b 8.73%
unlock
2030
$4.9b 11.54%
unlock
2031
$5.5b 11.30%
unlock
2032
$6.1b 11.93%
unlock
2033
$6.9b 11.62%
unlock

Net Margin

2025 18.89% 48.87%
2026
29.45% 55.94%
unlock
2027
31.19% 5.91%
unlock
2028
33.10% 6.12%
unlock
2029
33.52% 1.27%
unlock
2030
33.94% 1.25%
unlock
2031
34.27% 0.97%
unlock
2032
34.79% 1.52%
unlock
2033
35.44% 1.87%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Oct '25 Oct '26
Estimates
Earnings Per Share $ 2.39 4.21
66.48% 76.15%

30 Analysts have issued a Synopsys forecast for earnings per share. The average Synopsys EPS is

$15.24
unlock
. This is
172.63% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$15.94 185.15%
unlock
, the lowest is
$14.10 152.24%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $8.04 44.59%
2026
$15.24 89.55%
unlock
2027
$17.92 17.59%
unlock
2028
$21.21 18.36%
unlock
2029
$23.06 8.72%
unlock
2030
$25.72 11.54%
unlock
2031
$28.63 11.31%
unlock
2032
$32.05 11.95%
unlock
2033
$35.77 11.61%
unlock

P/E ratio

Current 76.16 89.83%
2026
27.94 63.32%
unlock
2027
23.76 14.96%
unlock
2028
20.07 15.53%
unlock
2029
18.46 8.02%
unlock
2030
16.55 10.35%
unlock
2031
14.87 10.15%
unlock
2032
13.28 10.69%
unlock
2033
11.90 10.39%
unlock

Based on analysts' sales estimates for 2026, the Synopsys stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.47 41.29%
2026
8.99 5.07%
unlock
2027
8.10 9.90%
unlock
2028
7.26 10.35%
unlock
2029
6.76 6.87%
unlock
2030
6.14 9.23%
unlock
2031
5.57 9.27%
unlock
2032
5.05 9.31%
unlock
2033
4.61 8.74%
unlock

P/S ratio

Current 8.66 39.42%
2026
8.23 5.04%
unlock
2027
7.41 9.90%
unlock
2028
6.65 10.35%
unlock
2029
6.19 6.87%
unlock
2030
5.62 9.23%
unlock
2031
5.10 9.27%
unlock
2032
4.62 9.31%
unlock
2033
4.22 8.74%
unlock

Current Synopsys Upgrades & Downgrades

Analyst Rating Action Date
Wells Fargo
Equal-Weight
➜
Overweight
Upgrade Sep 10 2026
Morgan Stanley
Equal-Weight
➜
Overweight
Upgrade Sep 08 2026
Rosenblatt
Buy
➜
Buy
Unchanged Aug 27 2026
Benchmark
Buy
➜
Buy
Unchanged Aug 27 2026
Mizuho
Outperform
➜
Outperform
Unchanged Aug 27 2026
Needham
Buy
➜
Buy
Unchanged Aug 27 2026
Baird
Neutral
➜
Outperform
Upgrade Aug 27 2026
Analyst Rating Date
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
Sep 10 2026
Upgrade
Morgan Stanley:
Equal-Weight
➜
Overweight
Sep 08 2026
Unchanged
Rosenblatt:
Buy
➜
Buy
Aug 27 2026
Unchanged
Benchmark:
Buy
➜
Buy
Aug 27 2026
Unchanged
Mizuho:
Outperform
➜
Outperform
Aug 27 2026
Unchanged
Needham:
Buy
➜
Buy
Aug 27 2026
Upgrade
Baird:
Neutral
➜
Outperform
Aug 27 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today